ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0633

Vitamin D Serum Status in a Cohort of COVID-19 Patients

Alberto Sulli1, Emanuele Gotelli1, Sabrina Paolino1, Andrea Casabella1, Carmen Pizzorni1, Elisa Alessandri1, Vanessa Smith2 and Maurizio Cutolo1, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic, Genoa, Italy, 2Department of Rheumatology, Ghent University Hospital, Department of Internal Medicine, VIB Inflammation Research Centre Ghent University, Ghent, Belgium

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, COVID-19, Infection, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Vitamin D serum levels have been inversely associated with risk of pulmonary infections and autoimmune inflammatory disease activity and severity [1,2]. A possible role of vitamin D in patients with SARS-Cov-2 infection was also recently reported [3]. 
The aim of the study was to evaluate 25OH-vitamin D serum levels in a cohort of patients hospitalized for SARS-Cov-2 infection, looking in particular for correlations with parameters of lung involvement. 

Methods: Sixty consecutive COVID-19 patients (mean age 76±8 years, mean disease duration 13±13 days, 26 males and 34 females) and sixty sex- and age-matched healthy subjects (CNT) were evaluated. Pulmonary involvement (radiological findings), respiratory parameters (PaO2/FIO2, pO2, sO2), clinical parameters, duration of hospitalization and global disease duration were recorded.

Results: Vitamin D serum levels were found significantly lower in COVID-19 patients than in CNT (median 7.8 vs 16.0 ng/ml, p=0.0003). Among COVID-19, vitamin D sufficiency ( >30 ng/ml), insufficiency (between 20 and 30 ng/ml) deficiency (between 10 and 20 ng/ml) and severe deficiency (< 10 ng/ml) were observed respectively in 11, 12, 20 and 57 % of patients. In CNT, the same vitamin D distribution occurred in 21, 22, 34 and 23 % of subjects respectively.

A statistically significant positive correlation was observed between vitamin D serum levels and PaO2/FIO2 (p=0.02), pO2 (p=0.04), sO2 (p=0.05), while a statistically significant negative correlation was found between vitamin D serum levels and percentage of O2 in Venturi Mask (p=0.04). Vitamin D serum levels negatively correlated also with C-reactive protein (p=0.04), D-dimer (p=0.04), and parathyroid hormone (p=0.05).

A negative correlation was also found between vitamin D levels and severity of radiographic pulmonary involvement, but this did not reach the statistical significance (median vitamin D levels in patients with Mild, Moderate and Severe lung involvement were respectively 10.9, 7.7 and 5.5 ng/dl; p=0.11). However, vitamin D serum levels were found significantly lower in COVID-19 patients with either multiple lung consolidations or severe interstitial lung involvement than in those with either normal or mild interstitial lung involvement (p=0.02).

Finally, lower vitamin D serum levels were found associated with longer global disease duration (p=0.05).

Conclusion: Deficiency of 25OH-vitamin D serum levels seem associated with more severe lung involvement and longer disease duration in COVID-19 patients.

References. 1. Zittermann A et al. Eur J Med Res (2016) 21:14. 2. Cutolo M et al. Ann N Y Acad Sci (2014) 1317:39-46. 3. Weir EK et al. Clin Med (Lond) (2020) 20:4.


Disclosure: A. Sulli, None; E. Gotelli, None; S. Paolino, None; A. Casabella, None; C. Pizzorni, None; E. Alessandri, None; V. Smith, Boehringer Ingelheim, 2, 5, 8, Janssen, 2, 5, 8; M. Cutolo, None.

To cite this abstract in AMA style:

Sulli A, Gotelli E, Paolino S, Casabella A, Pizzorni C, Alessandri E, Smith V, Cutolo M. Vitamin D Serum Status in a Cohort of COVID-19 Patients [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/vitamin-d-serum-status-in-a-cohort-of-covid-19-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vitamin-d-serum-status-in-a-cohort-of-covid-19-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology